Incident Report
Subform I: General Information
1. Report Type.
New incident report
Incident Report Number: 2015-1482
2. Registrant Information.
Registrant Reference Number: Ont
Registrant Name (Full Legal Name no abbreviations): x
Address: x
City: x
Prov / State: x
Country: x
Postal Code: X
3. Select the appropriate subform(s) for the incident.
Human
4. Date registrant was first informed of the incident.
5. Location of incident.
Country: CANADA
Prov / State: ONTARIO
6. Date incident was first observed.
23-JAN-15
Product Description
7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.
Active(s)
PMRA Registration No. 24175
PMRA Submission No.
EPA Registration No.
Product Name: DRAGNET FT EMULSIFIABLE CONCENTRATE INSECTICIDE
PMRA Registration No. 15255
PMRA Submission No.
EPA Registration No.
Product Name: DRIONE INSECTICIDE DUST
- Active Ingredient(s)
- PIPERONYL BUTOXIDE
- PYRETHRINS
- SILICA AEROGEL
7. b) Type of formulation.
Application Information
8. Product was applied?
Yes
9. Application Rate.
1
Units: %
10. Site pesticide was applied to (select all that apply).
Site: Res. - In Home / Rés. - à l'int. maison
11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).
The pest control company reports using Dragnet FT (PCPA 24175) as a 1% emulsion to treat the underside of the couch and its frame. Dragnet FT was used to perform a crack and crevice baseboard treatment to the perimether of the affected rooms. In addition, Drione Insecticide Dust was applied through the wall outlets. Steam was also used to treat the bed, mattress, etc..The product was applied by a provincially licensed Pest Control Operator at double the application rate for the control of bedbugs (although the application rate used is allowed on the label for control of other pests indoors).
To be determined by Registrant
12. In your opinion, was the product used according to the label instructions?
Unknown
Subform II: Human Incident Report (A separate form for each person affected)
1. Source of Report.
Other
2. Demographic information of data subject
Sex: Male
Age: Unknown / Inconnu
3. List all symptoms, using the selections below.
System
- Gastrointestinal System
- Symptom - Other
- Specify - throat inflammation
- Respiratory System
- Symptom - Other
- Specify - chest inflammation
- Gastrointestinal System
- Symptom - Mouth Irritation
- Specify - mouth inflammation
4. How long did the symptoms last?
Unknown / Inconnu
5. Was medical treatment provided? Provide details in question 13.
Unknown
6. a) Was the person hospitalized?
No
6. b) For how long?
7. Exposure scenario
Non-occupational
8. How did exposure occur? (Select all that apply)
Contact with treated area
Amount of time between application and contact 5
Hour(s) / Heure(s)
9. If the exposure occured during application or re-entry, what protective clothing was worn? (select all that apply)
None
10. Route(s) of exposure.
Unknown
11. What was the length of exposure?
Unknown / Inconnu
12. Time between exposure and onset of symptoms.
Unknown / Inconnu
13. Provide any additional details about the incident (eg. description of the frequency and severity of the symptoms, type of medical treatment, results from medical tests, outcome of the incident, amount of pesticide exposed to, etc.)
The Ministry of the Environment and Climate Change (MOECC) has received a complaint from a tenant at an (city) apartment building. The complainant reports that his unit was treated for bedbugs on Jan 23rd. He returned to his unit 5 hours following the treatment and reports that shortly thereafter, he started 'experiencing mouth, throat and chest inflammation'. He then left the apartment building and spent the night elsewhere. The complainant attended the hospital on January 24 and was informed by the doctor that he had a reaction to a pesticide application.The complainant has not returned to his apartment.
To be determined by Registrant
14. Severity classification.
15. Provide supplemental information here.